Boundless Bio, Inc. (BOLD) — 分析师展望 / 分析师共识目标价为. 基于 20 位分析师评级, 共识为 看涨 — 6 买入, 13 持有, 1 卖出.
分析师预估 每股收益(EPS)为 $-3.83 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-3.85 vs 预期 $-3.83 (不及预期 -0.5%). 2025: 实际 $-2.60 vs 预期 $-2.47 (不及预期 -5.3%). 分析师准确度: 97%.
BOLD 分析师评级
Hold
基于过去3个月内 20 位分析师对 Boundless Bio, Inc. 的评级
EPS 预测 — BOLD
97%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$3.85
vs Est –$3.83
▼ 0.5% off
2025
Actual –$2.60
vs Est –$2.47
▼ 5.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — BOLD
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
